Cammarota, Gianmaria
Bruni, Andrea
Morettini, Giulio
Vitali, Leonardo
Brunelli, Francesco
Tinarelli, Filippo
Simonte, Rachele
Rossi, Elisa
Bellucci, Matteo
De Girolamo, Giacomo
Galzerano, Antonio
Vetrugno, Luigi
Maggiore, Salvatore M.
Bignami, Elena
Azzolina, Danila
Dow, Olivia
Navalesi, Paolo
De Robertis, Edoardo
Article History
Received: 15 December 2022
Accepted: 17 January 2023
First Online: 25 January 2023
Declarations
:
: The present investigation is a secondary analysis of data prospectively collected to ascertain the characteristics and clinical course of COVID-19 patients in the ICU of the “Servizio di Anestesia e Rianimazione 2—Azienda Ospedaliera di Perugia, Italy” after approval of by the local ethical committee (Protocol No 3658/20). The study was conducted according to the principles outlined in the Helsinki Declaration, and written informed consent was waived owing to the observational nature of the study design, since all the patients were treated according to standard clinical practice and institutional protocol.
: Not applicable.
: Prof Gianmaria Cammarota and Prof Edoardo De Robertis declares speaking honoraria from MSD and Getinge outside the present work. In addition, Prof Edoardo De Robertis received speaking honoraria from Baxter outside the present investigation. Prof Salvatore M Maggiore disclose having received speaking fees from GE Healthcare, Masimo, and Aspen outside the present work. Prof Paolo Navalesi declares to have received: grants, personal fees and non-financial support from Maquet Critical Care—Getinge; grants and non-financial support from Draeger and Intersurgical S.p.A; and personal fees from Gilead, Philips, Resmed, MSD, and Novartis, in each case for reasons that remain unrelated to the submitted work. Prof. Navalesi also contributed to the development of the patented ‘helmet Next’, the royalties for which are paid to Intersurgical Spa. Prof. Navalesi contributed to the development of a device not discussed in the present study with patent application number: EP20170199831. No conflict of interest must be declared by the remaining authors.